π¦ Comprehensive Clinical Microbiology Tutorial for Medical Students π§¬
-
1. INTRODUCTION TO MICROBIOLOGY π₯
- π¬ Microbiology = Study of microorganisms: Bacteria π¦ , Viruses π§¬, Fungi π, Parasites π
- π₯ Clinical Microbiology = Diagnosis & treatment of infectious diseases
- π Key concepts:
- π₯ Normal flora vs. π Pathogens
- πͺ Opportunistic infections (immunocompromised)
- π Colonization vs. π₯ Infection
- π‘οΈ Virulence factors: Toxins, enzymes, capsules
-
2. BACTERIOLOGY π¦
-
2.1 Bacterial Structure π¬
- π§± Cell wall:
- π Gram +: Thick peptidoglycan β Retains crystal violet
- π©· Gram -: Thin peptidoglycan + outer membrane β Pink
- π‘οΈ Capsule: Streptococcus pneumoniae, Haemophilus influenzae
- πββοΈ Flagella: Motility (E. coli, Proteus)
- π Pili: Adherence (Gonorrhea)
- π£ Spores: Clostridium, Bacillus (heat resistant)
-
2.2 Gram Staining Procedure π¨
- π΅ Crystal violet β π£ Iodine β π§ Alcohol (decolorizes Gram -) β π£ Safranin
- π Gram +: Purple (thick peptidoglycan)
- π©· Gram -: Pink (lipopolysaccharide outer membrane)
-
2.3 Gram Positive Cocci π΅
- π‘ Staphylococcus aureus "Golden Staph"
- π Golden colonies, π§ͺ Catalase +, π©Έ Coagulase +
- π₯ Diseases: Cellulitis, Abscesses, Pneumonia, Osteomyelitis, Endocarditis, TSS
- β οΈ MRSA: Methicillin-resistant (vancomycin)
- π§ͺ Mannitol salt agar: Yellow colonies
- π΄ Streptococcus pyogenes (Group A Ξ²-hemolytic)
- π©Έ Beta-hemolytic, π Bacitracin sensitive, π§ͺ PYR +
< Lancefield A, M protein, Erythrogenic toxin
- π₯ Pharyngitis, Impetigo, Scarlet fever, Necrotizing fasciitis, Rheumatic fever
- π’ Streptococcus pneumoniae "Pneumococcus"
- π©Έ Alpha-hemolytic, π Optochin sensitive, π§ͺ Bile soluble, Quellung reaction
- π₯ Lobar pneumonia, Meningitis, Otitis media, Sinusitis
- π PCV13, PPSV23 vaccines
- β« Enterococcus faecalis/vimcinus
- π§ͺ Gut flora, Bile esculin +, PYR +, Grows in 6.5% NaCl
- π₯ UTI, Endocarditis, Abdominal infections
- β οΈ VRE: Vancomycin-resistant
-
2.4 Gram Positive Bacilli π£
- π€ Clostridium difficile
- π© Pseudomembranous colitis (abx-associated), π§ͺ Toxin A/B EIA
- π Vancomycin PO, Fidaxomicin
- β« Bacillus anthracis "Anthrax"
- π Spores, π©Έ Non-hemolytic, π§ͺ Medusa head colonies
- π₯ Cutaneous, GI, Pulmonary (Woolsorter's disease)
- π£ Corynebacterium diphtheriae
- β« Gray pseudomembrane, π§ͺ Tellurite agar (black colonies)
- π Diphtheria toxin β Myocarditis
- π’ Listeria monocytogenes
- π₯ͺ Cold enrichment, Tumbling motility at 25Β°C, Beta-hemolytic
- π₯ Pregnant women, neonates, elderly β Meningitis
-
2.5 Gram Negative Cocci π©·
- π΄ Neisseria gonorrhoeae
- π Gonorrhea, Chocolate agar, Oxidase +, Gram - diplococci
- π Ceftriaxone + Azithromycin (resistance rising)
- π£ Neisseria meningitidis
- π§ Meningitis, Waterhouse-Friderichsen syndrome, Petechial rash
- π MenACWY, MenB vaccines
-
2.6 Gram Negative Bacilli π©·
- Enterobacteriaceae π₯ (E. coli, Klebsiella, Proteus, Salmonella)
- π§ͺ MacConkey agar:
- π£ Lactose fermenters: E. coli, Klebsiella (pink)
- βͺ Non-lactose: Salmonella, Shigella (colorless)
- π£ E. coli: #1 UTI, Traveler's diarrhea (ETEC), HUS (O157:H7)
- π£ Klebsiella: Currant jelly sputum, Alcoholics
- π£ Salmonella: Typhoid (S. typhi), Gastroenteritis (S. enteritidis)
- π£ Shigella: Bacillary dysentery, Shiga toxin
- π’ Pseudomonas aeruginosa
- π Green pus, Sweet grape smell, UTI (catheters), Burn patients
- π§ͺ Pigment: Pyocyanin (blue), Pyoverdin (fluorescent)
- π΄ Haemophilus influenzae
- π« Chocolate agar, X&V factors, π Hib vaccine
- π₯ Epiglottitis, Meningitis (pre-vaccine era)
- π Legionella pneumophila
- π° Legionnaires' disease, Pontiac fever, Urine antigen
- π Levofloxacin, Azithromycin
-
2.7 Anaerobes π·
- π€ Bacteroides fragilis: Abdominal infections, Penicillin resistant
- β« Clostridium perfringens: Gas gangrene, Food poisoning
- π¦ Actinomyces israelii: Sulfur granules, Cervicofacial
-
2.8 Spirochetes π
- π£ Treponema pallidum: Syphilis
- 1Β° Chancre, 2Β° Rash, 3Β° Gummas/Tabes dorsalis/Neurosyphilis
- π§ͺ VDRL/RPR (screen), FTA-ABS (confirm)
- π’ Borrelia burgdorferi: Lyme disease (bull's eye rash)
- π Leptospira: Weil's disease (rat urine)
-
2.9 Acid-Fast Bacilli π΄
- π£ Mycobacterium tuberculosis
- π¬ Ziehl-Neelsen stain, Caseating granulomas, Night sweats
- π§ͺ AFB culture (6-8 weeks), Nucleic acid amplification
- π BCG vaccine (limited efficacy)
-
3. VIROLOGY π§¬
-
3.1 DNA Viruses π§¬
- π£ Herpesviruses (Enveloped, Latency):
- π HSV-1: Oral herpes
- π HSV-2: Genital herpes
- π€ VZV: Chickenpox β Shingles
- ποΈ CMV: Retinitis (AIDS), Mono-like
- π EBV: Mono, Burkitt lymphoma
- π’ Adenovirus: Conjunctivitis, Pneumonia, Gastroenteritis
- π Poxvirus: Smallpox, Molluscum contagiosum
- π£ HPV: Warts, Cervical cancer (16,18)
- π£ Hepatitis B: Dane particle, HBsAg, Anti-HBc IgM
-
3.2 RNA Viruses π§¬
- π΄ Orthomyxovirus: Influenza A/B/C β Antigenic drift/shift
- π£ Paramyxovirus: Measles (Koplik spots), Mumps, RSV
- π’ Picornavirus: Polio, Hep A, Rhinovirus, Enterovirus
- π Flavivirus: Hep C, Dengue, Zika, Yellow fever
- π£ Coronaviruses: SARS-CoV-2, MERS, Common cold
- π΄ Retroviruses: HIV (RT, CD4), HTLV (Adult T-cell leukemia)
- π’ Togavirus: Rubella (congenital defects)
-
4. MYCOLOGY π
- π£ Candida albicans: Thrush, Vaginitis, Esophageal (HIV), Catheter lines
- π§ͺ Germ tube test, KOH prep (pseudohyphae)
- β« Cryptococcus neoformans: Meningitis (AIDS), India ink (halo), Antigen test
- π€ Histoplasma capsulatum: Ohio/Mississippi valley, Bat/bird guano, Lung granulomas
- π Coccidioides immitis: San Joaquin Valley fever, Desert rheumatism
- π£ Blastomyces dermatitidis: Broad-based budding, Skin/lung
- π’ Aspergillus fumigatus: Allergic bronchopulmonary, Invasive (neutropenic)
- β« Mucor/Rhizopus: Diabetics, Rhinocerebral, Angioinvasive
-
5. PARASITOLOGY π
-
5.1 Protozoa π¦
- π©Έ Plasmodium falciparum: Malaria (cerebral, Blackwater fever)
- π§ Giardia lamblia: Waterborne diarrhea, Stool antigen
- π« Entamoeba histolytica: Flask-shaped ulcers, Liver abscess
- π± Toxoplasma gondii: Cats, Ring-enhancing lesions (AIDS)
- π¦ Trypanosoma: African sleeping sickness (T. gambiense), Chagas (T. cruzi)
-
5.2 Helminths πͺ±
- π Ascaris lumbricoides: Largest roundworm, Lung migration
- π· Trichinella spiralis: Undercooked pork, Periorbital edema
- π Schistosoma: Swimmer's itch, Portal hypertension, Eggs in urine/stool
-
6. LABORATORY DIAGNOSIS π§ͺ
-
6.1 Culture Media π§«
- π©Έ Blood agar: Most bacteria
- π£ MacConkey: Gram - enteric (lactose pink)
- π« Chocolate agar: Haemophilus, Neisseria
- π’ Sabouraud agar: Fungi
- π€ Lowenstein-Jensen: Mycobacteria (egg-based)
-
6.2 Stains π¬
- ππ©· Gram stain: Bacteria
- π΄ Acid-fast (Ziehl-Neelsen): TB, Nocardia
- β« India ink: Cryptococcus capsule
- π©Έ Giemsa/Wright: Malaria, Borrelia
-
7. ANTIBIOTICS π
-
7.1 Beta-Lactams π‘οΈ
- π Penicillins: Strep, Meningococcus
- π£ Cephalosporins: 1st gen (Gram+), 3rd/4th (Gram-)
- π’ Carbapenems: Broadest (ESBL, anaerobes)
-
8. HIGH-YIELD EXAM FACTS π―
- Never miss:
- π‘ S. aureus = Surgical wounds, Endocarditis
- π’ S. pneumoniae = Lobar pneumonia, Otitis
- π£ E. coli = #1 UTI pathogen
- π€ C. difficile = Abx diarrhea
π©Ί UK-SPECIFIC ORGAN-SPECIFIC INFECTIONS & TREATMENT GUIDELINES π₯
Based on NICE (NG250 for pneumonia, NG109/113 for UTI, NG141 for SSTI, NG240 for meningitis, NG199 for C. diff), BASHH for STIs, BSAC for endocarditis, and other UK sources like PHE/UKHSA. Always consult local guidelines, BNF, and specialists. Dates reflect latest updates as of 2025.
-
1. RESPIRATORY TRACT INFECTIONS π¬οΈ
-
1.1 Community-Acquired Pneumonia (CAP) π«
- Most Common Pathogens:
- π’ S. pneumoniae (mainstay)
- π£ Mycoplasma pneumoniae, Legionella, C. pneumoniae (atypicals)
- π H. influenzae (esp. in COPD)
- Assessment: Use CRB-65 score (NICE NG250). Score 0-1: Outpatient; 2: Hospital; β₯3: Urgent hospital.
- Treatment (NICE NG250):
- πΆββοΈ Low severity (outpatient): Amoxicillin 500mg TDS x 5 days (first-line). If atypical suspected or penicillin allergy: Doxycycline 200mg day 1, then 100mg OD x 4 days OR Clarithromycin 500mg BD x 5 days.
- π₯ High severity (hospital, non-ICU): Co-amoxiclav 1g TDS IV/PO + Clarithromycin 500mg BD. Switch to oral when stable.
- π Severe/ICU: Co-amoxiclav + Clarithromycin + consider adding Levofloxacin if Legionella risk. Add Corticosteroids (e.g., hydrocortisone) for high-severity.
- Duration: 5 days; extend if not improving.
-
1.2 Hospital-Acquired Pneumonia (HAP) ποΈ
- Pathogens: Gram-negatives (Pseudomonas), MRSA.
- Treatment (NICE NG139): Pip/taz 4.5g TDS IV OR Cefuroxime 1.5g TDS + Metronidazole if anaerobic risk. Add MRSA cover if needed (Vancomycin). Start within 1-4 hours.
-
1.3 Pharyngitis/Tonsillitis π€
- Group A Strep (Centor score β₯3): Phenoxymethylpenicillin (Pen V) 500mg QDS x 10 days (NICE). Allergy: Clarithromycin 250mg BD x 5 days.
-
2. URINARY TRACT INFECTIONS (UTI) π½
-
2.1 Uncomplicated Lower UTI (Cystitis) π§
- #1 Pathogen: π£ E. coli.
- Treatment (NICE NG109): Non-pregnant women: Nitrofurantoin 100mg BD x 3 days (first-line). Alternatives: Trimethoprim 200mg BD x 3 days (if resistance <20%). Pregnant women: Nitrofurantoin x 7 days (avoid 3rd trimester). Men: x 7 days.
- Delay if mild: Back-up prescription with self-care advice.
-
2.2 Acute Pyelonephritis π©Έ
- Treatment (NICE NG109): Ciprofloxacin 500mg BD x 7 days (avoid if resistance high; MHRA warnings). Alternatives: Co-amoxiclav 500/125mg TDS x 7-10 days OR Cefalexin 500mg QDS x 7-10 days.
-
2.3 Catheter-Associated UTI π©Ή
- Treatment (NICE NG113): Only treat symptomatic. Ciprofloxacin 500mg BD x 7 days OR Co-amoxiclav. Remove/replace catheter.
-
3. SKIN & SOFT TISSUE INFECTIONS π©Ή
-
3.1 Cellulitis/Erysipelas π‘
- Pathogens: π‘ S. aureus, π΄ S. pyogenes.
- Treatment (NICE NG141): Flucloxacillin 500mg QDS x 5-7 days (PO). Severe: IV 1-2g QDS. Allergy: Clarithromycin 500mg BD OR Clindamycin 300mg QDS.
- MRSA risk: Clindamycin or Doxycycline.
-
3.2 Abscess/Boil π©Έ
- I&D primary. Antibiotics if systemic symptoms: Flucloxacillin + Clindamycin for MRSA cover.
-
3.3 Necrotizing Fasciitis β οΈ
- Treatment: Urgent surgery + Clindamycin 600-900mg IV TDS (toxin suppression) + broad-spectrum (e.g., Pip/taz 4.5g TDS).
-
4. CENTRAL NERVOUS SYSTEM π§
-
4.1 Bacterial Meningitis (Age-Based) π
- Empiric (NICE NG240/UK JSSG): Give IV antibiotics ASAP (within 1 hour if sepsis). Ceftriaxone 2g BD (adults) + Dexamethasone 10mg IV QDS (before/with first dose, if pneumococcal suspected).
- Neonates: Cefotaxime + Ampicillin (Listeria cover).
- Children/Young Adults: Ceftriaxone (meningococcus/pneumococcus).
- Adults >50/Elderly: Add Ampicillin 2g QDS for Listeria.
- Duration: 7-14 days depending on organism.
-
4.2 Brain Abscess π©Έ
- Treatment: Ceftriaxone 2g BD + Metronidazole 400mg TDS + consider Flucloxacillin. Surgery if needed.
-
5. GASTROINTESTINAL INFECTIONS π€’
-
5.1 Bacterial Diarrhea π¦
-
| Pathogen | Treatment (NICE/PHE) |
| π£ Salmonella (non-typhi) | Supportive (avoid abx unless severe) |
| π£ Shigella | Ciprofloxacin 500mg BD x 3 days |
| π€ C. difficile | Vancomycin 125mg QDS PO x 10 days (first-line, NICE NG199). Severe/recurrent: Fidaxomicin 200mg BD x 10 days. Stop offending abx. |
| π£ Campylobacter | Supportive; Azithromycin if severe |
-
5.2 Intra-abdominal Infections π«
- Treatment: Pip/taz 4.5g TDS IV OR Ceftriaxone 2g OD + Metronidazole 400mg TDS.
-
6. SEXUALLY TRANSMITTED INFECTIONS π
-
| Disease | Pathogen | Treatment (BASHH 2023/2024) |
| π¦ Gonorrhea | N. gonorrhoeae | Ceftriaxone 1g IM single dose + Azithromycin 2g PO single dose (or Doxycycline 100mg BD x 7d if macrolide allergy) |
| π΄ Chlamydia | C. trachomatis | Doxycycline 100mg BD x 7 days (first-line) OR Azithromycin 1g single dose |
| π£ Syphilis | T. pallidum | Benzathine penicillin 2.4g IM (early); 3 doses weekly (late). Alternative: Doxycycline 100mg BD x 14/28 days |
| π¦ Trichomoniasis | T. vaginalis | Metronidazole 400mg BD x 5-7 days OR 2g single dose |
-
7. BONE & JOINT INFECTIONS π¦΄
-
7.1 Osteomyelitis π¦΄
- Empiric: Flucloxacillin 1-2g QDS IV (S. aureus cover). Add Clindamycin if MRSA.
- Duration: 4-6 weeks total (IV 1-2 weeks, then oral switch if stable, per BSAC/BOA).
- Children: Early OPAT consideration (BOAST).
-
7.2 Septic Arthritis π§
- Treatment: Urgent aspiration/drainage + Flucloxacillin IV. Gonococcal: Ceftriaxone.
- Duration: 2-4 weeks IV/PO.
-
8. ENDOCARDITIS β€οΈ
-
| Organism | Treatment (BSAC/BNF) | Duration |
| π’ Viridans Strep (sensitive) | Benzylpenicillin 1.8g QDS IV | 4 weeks |
| π΄ S. aureus (MSSA) | Flucloxacillin 2g QDS IV | 4-6 weeks |
| π‘ S. aureus (MRSA) | Vancomycin IV (trough 10-20mg/L) | 4-6 weeks |
| β« Enterococcus | Ampicillin 2g QDS + Gentamicin 1mg/kg TDS | 4-6 weeks |
| π£ HACEK | Ceftriaxone 2g BD IV | 4 weeks |
- Empiric: Vancomycin + Gentamicin + Flucloxacillin or Piperacillin/tazobactam.
-
9. HIGH-YIELD EMERGENCY ANTIBIOTICS π―
- Neutropenic Fever: Pip/taz 4.5g TDS IV (or Ceftazidime).
- Meningitis (empiric): Ceftriaxone 2g BD IV + Dexamethasone.
- Sepsis (empiric): Pip/taz + Gentamicin (NICE sepsis bundle).
- Bite wounds: Co-amoxiclav 500/125mg TDS x 5 days (NICE NG184).
- Catheters: Vancomycin + remove device.
-
10. RESISTANCE PATTERNS β οΈ
- MRSA: Vancomycin, Daptomycin, Linezolid.
- VRE: Linezolid, Daptomycin.
- ESBL: Carbapenems (e.g., Ertapenem).
- Pseudomonas: Dual therapy e.g., Ceftazidime + Ciprofloxacin.
**π©Ί KEY TAKEAWAYS FOR UK EXAMS (PLAB/MRCP):**
- **NICE emphasis: Antimicrobial stewardship, short courses, local resistance data.
- **MRSA/Pseudomonas: Risk assess (hospitalisation, ICU).
- **Sepsis: Within 1 hour antibiotics (NICE NG51).
- **Prophylaxis: No routine for IE (NICE CG64); focus on hygiene.
- **Always: Source control + de-escalate based on cultures. Consult BNF for doses.